IR@PKUHSC  > 北京大学临床肿瘤学院  > 胸部肿瘤内科
学科主题临床医学
BIOMARKER ANALYSIS OF A RANDOMIZED, CONTROLLED, MULTICENTER CLINICAL TRIAL COMPARING PEMETREXED/CISPLATIN AND GMCITABINE/CISPLATIN AS FIRST-LINE TREATMENT FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
Zhang, Li1; Huang, Yan1; Hu, Zhihuang1; Liu, Yun-Peng2; Zhou, Jianying3; Xu, Nong4; Li, Baolan5; Wu, Gang6; Liu, Xiaoqing7; Fang, Jian8; Li, Kai9; Wei, Liu10; Lu, You11; Wang, Meng-Zhao12; Liu, Wenzhao13; Liang, Houjie14; Zhang, Yiping15; Huang, Cheng16; Wang, Shunjin17; Wang, Yajie18; Yu, Shiying19; Chang, Jianhua20; Wang, Zhehai21
关键词Lung Cancer Chemotherapy Biomarker
刊名JOURNAL OF THORACIC ONCOLOGY
2013-11-01
suppl.2页:S330-S330
收录类别SCI
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology ; Respiratory System
研究领域[WOS]Oncology ; Respiratory System
语种英语
WOS记录号WOS:000339624901188
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/57206
专题北京大学临床肿瘤学院_胸部肿瘤内科
北京大学临床肿瘤学院_日间化疗病区
作者单位1.Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
2.China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Liaoning, Peoples R China
3.Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Resp Dis, Hangzhou, Zhejiang, Peoples R China
4.Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Chemotherapy, Hangzhou, Zhejiang, Peoples R China
5.Capital Med Hosp, Beijing Chest Hosp, Dept Gen Med, Beijing, Peoples R China
6.Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Tumor Ctr, Wuhan, Hubei, Peoples R China
7.Acad Mil Med Sci, Affiliated Hosp, Dept Thorac Med Oncol, Beijing, Peoples R China
8.Beijing Canc Hosp & Inst, Dept Thorac Med Oncol, Beijing, Peoples R China
9.Tianjin Med Univ Canc Inst & Hosp, Dept Thorac Med Oncol, Tianjin, Peoples R China
10.Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
11.Sichuan Univ, West China Sch Med, West China Hosp, Dept Thorac Oncol, Chengdu, Sichuan, Peoples R China
12.Beijing Union Med Coll Hosp, Dept Resp Dis, Beijing, Peoples R China
13.Fourth Mil Med Univ, Xijing Hosp, Dept Oncol, Xian, Peoples R China
14.Third Mil Med Univ, Affiliated Hosp 1, Dept Oncol, Chongqing, Peoples R China
15.Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China
16.Fujian Prov Canc Hosp, Dept Thorac Oncol, Fuzhou, Fujian, Peoples R China
17.Nanchang Univ, Affiliated Hosp 2, Dept Oncol, Nanchang, Peoples R China
18.Shanghai Second Mil Med Univ, Changhai Hosp, Dept Oncol, Shanghai, Peoples R China
19.Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Caner Ctr, Wuhan, Hubei, Peoples R China
20.Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China
21.Shandong Canc Hosp, Dept Med Oncol, Jinan, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Li,Huang, Yan,Hu, Zhihuang,et al. BIOMARKER ANALYSIS OF A RANDOMIZED, CONTROLLED, MULTICENTER CLINICAL TRIAL COMPARING PEMETREXED/CISPLATIN AND GMCITABINE/CISPLATIN AS FIRST-LINE TREATMENT FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER[J]. JOURNAL OF THORACIC ONCOLOGY,2013,suppl.2:S330-S330.
APA Zhang, Li.,Huang, Yan.,Hu, Zhihuang.,Liu, Yun-Peng.,Zhou, Jianying.,...&Wang, Zhehai.(2013).BIOMARKER ANALYSIS OF A RANDOMIZED, CONTROLLED, MULTICENTER CLINICAL TRIAL COMPARING PEMETREXED/CISPLATIN AND GMCITABINE/CISPLATIN AS FIRST-LINE TREATMENT FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER.JOURNAL OF THORACIC ONCOLOGY,suppl.2,S330-S330.
MLA Zhang, Li,et al."BIOMARKER ANALYSIS OF A RANDOMIZED, CONTROLLED, MULTICENTER CLINICAL TRIAL COMPARING PEMETREXED/CISPLATIN AND GMCITABINE/CISPLATIN AS FIRST-LINE TREATMENT FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER".JOURNAL OF THORACIC ONCOLOGY suppl.2(2013):S330-S330.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhang, Li]的文章
[Huang, Yan]的文章
[Hu, Zhihuang]的文章
百度学术
百度学术中相似的文章
[Zhang, Li]的文章
[Huang, Yan]的文章
[Hu, Zhihuang]的文章
必应学术
必应学术中相似的文章
[Zhang, Li]的文章
[Huang, Yan]的文章
[Hu, Zhihuang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。